RSS feed (help and list of feeds)
PHO Newsletter
- 2010-03 PHO Newsletter (2 pages, 62 KB) 26 Feb 2010
- 2010-02 PHO Newsletter (1 page, 56 KB) 29 Jan 2010
- 2010-01 PHO Newsletter (1 page, 66 KB) 01 Jan 2010
- 2009-12 PHO Newsletter (1 page, 66 KB) 01 Dec 2009
- 2009-11 PHO Newsletter (1 page, 65 KB) 01 Nov 2009
- 2009-10 PHO Newsletter (1 page, 68 KB) 01 Oct 2009
- 2009-09 PHO Newsletter (1 page, 95 KB) 01 Sep 2009
- 2009-08 PHO Newsletter (1 page, 95 KB) 01 Aug 2009
- 2009-07 PHO Newsletter (1 page, 97 KB) 01 Jul 2009
- 2009-06 PHO Newsletter (1 page, 135 KB) 01 Jun 2009
Page updated on 26 Feb 2010
Linked documents
2010-03 PHO Newsletter (2 pages, 62 KB)
Pharmaceutical Management Agency PHO Newsletter Aromatase inhibitors There are some changes to the subsidises for aromatase inhibitors. In summary: March 2010 Anastrozole • Both DP-Anastrozole and Arimidex brands will remain fully funded from 1 February 2010. Arimidex remains fully funded…
2010-02 PHO Newsletter (1 page, 56 KB)
Pharmaceutical Management Agency PHO Newsletter Aromatase inhibitors – reference pricing February 2010 There are some changes to the subsidies of the aromatase inhibitors – anastrozole, letrozole and exemestane. These changes include the listing of a new brand of letrozole, as…
2010-01 PHO Newsletter (1 page, 66 KB)
Pharmaceutical Management Agency PHO Newsletter There are three new medicines listed from 1 January 2010 January 2010 Recent Pharmaceutical Schedule Changes Solifenacin succinate (Vesicare) 5 mg and 10 mg tablets will be listed with Special Authority criteria. It provides a…
2009-12 PHO Newsletter (1 page, 66 KB)
Pharmaceutical Management Agency PHO Newsletter Diclofenac sodium – new brands listed December 2009 Recent Pharmaceutical Schedule Changes Apotex’s diclofenac sodium long-acting 75 mg and 100 mg tablets (Apo-Diclo SR) are currently out of stock. PHARMAC has listed two alternate brands…
2009-11 PHO Newsletter (1 page, 65 KB)
Pharmaceutical Management Agency PHO Newsletter Mirtazapine – new listing November 2009 Recent Pharmaceutical Schedule Changes The antidepressant mirtazapine (Avanza) will be subsidised from 1 November 2009. Mirtazapine tablets will be subsidised subject to Special Authority criteria. See page 14 of…
2009-10 PHO Newsletter (1 page, 68 KB)
Pharmaceutical Management Agency PHO Newsletter Clarithromycin for helicobacter pylori eradication October 2009 Recent Pharmaceutical Schedule Changes A new strength of clarithromycin 500 mg tablets will be subsidised from 1 October 2009 specifically for use in the treatment of helicobacter pylori…
2009-09 PHO Newsletter (1 page, 95 KB)
Pharmaceutical Management Agency PHO Newsletter Nicotine Replacement Therapy – available on prescription September 2009 Recent Pharmaceutical Schedule Changes Nicotine replacement therapy (NRT) will be subsidised on either a prescription or a Quit Card from 1 September 2009. This means prescribers…
2009-08 PHO Newsletter (1 page, 95 KB)
Pharmaceutical Management Agency PHO Newsletter Enoxaparin sodium - new listings August 2009 Recent Pharmaceutical Schedule Changes The low molecular weight heparin Clexane injection (enoxaparin sodium) will be listed on the Pharmaceutical Schedule under Special Authority criteria from 1 August 2009.…
2009-07 PHO Newsletter (1 page, 97 KB)
Pharmaceutical Management Agency PHO Newsletter Methylphenidate - new listings July 2009 Recent Pharmaceutical Schedule Changes The Ritalin, Ritalin SR and Ritalin LA brands of the Attention Deficit/Hyperactivity Disorder (ADHD) treatment methylphenidate hydrochloride will be fully subsidised subject to Special Authority…
2009-06 PHO Newsletter (1 page, 135 KB)
Pharmaceutical Management Agency PHO Newsletter Pharmaceutical Omeprazole Simvastatin Paracetamol Only Fully Subsidised Brand Dr Reddys Omeprazole Arrow-Simva (from August) Pharmacare Paracetamol June 2009 Recent Pharmaceutical Schedule Changes Brand that is no longer Subsidised Losec Lipex (from August) Panadol Metoprolol succinate…
